Vaxfab Enterprises reported FY26 standalone profits of ₹3.64 crore but a consolidated net loss of ₹4.63 crore. Crucially, its auditor issued a 'Disclaimer of Opinion' due to record-keeping issues, raising serious concerns about financial transparency.

Vaxfab Enterprises FY26 Results: Auditor Issues Disclaimer of Opinion

Vaxfab Enterprises reported standalone revenue of ₹94.11 crore and a standalone profit of ₹3.64 crore for the year ended March 31, 2026. Consolidated revenue stood at ₹131.26 crore, with a consolidated net loss of ₹4.63 crore.

What just happened

The most significant development is the 'Disclaimer of Opinion' issued by the statutory auditor, M/S Chandabhoy & Jassoobhoy, on both standalone and consolidated financial results for the fiscal year 2026.

Why this matters

A 'Disclaimer of Opinion' means the auditor could not obtain sufficient evidence to form an opinion on whether the financial statements present a true and fair view. This raises serious questions about the reliability of Vaxfab's reported financials and impacts investor confidence.

The backstory

The auditors cited inadequacies in maintaining records by previous management, lack of supporting documentation for sales, purchases, and inventory, unsecured loans without formal agreements, and non-compliance with MSMED Act records.

What changes now

While management claims these issues have no impact on financial results and are due to non-accessibility of documents, the auditor's disclaimer remains. This suggests significant internal control weaknesses that investors must consider.

Risks to watch

The primary risk is the inability to trust the reported financial figures. The repetitive nature of audit qualifications indicates persistent governance and internal control issues. Potential regulatory scrutiny could also be a risk.

Peer comparison

While specific peer financial data for this exact period isn't directly comparable without context, audit disclaimers are rare and indicate a significant deviation from standard corporate governance practices seen in financially healthy peers.

Context metrics (time-bound)

Standalone FY26 Profit: ₹3.64 crore
Consolidated FY26 Loss: ₹4.63 crore
Auditor: M/S Chandabhoy & Jassoobhoy

What to track next

Investors should closely monitor any further disclosures from the company or regulatory bodies regarding these audit qualifications and the steps being taken to rectify the internal control and record-keeping deficiencies.